No matches

52 search results for: quality of life

Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?
Rhinology
Should we Still Operate on Patients With Chronic Rhinosinusitis With Nasal Polyps?
expert video

This video clip from the EAACI 2024 symposium discusses whether patients with CRSwNP should undergo a surgery.

View more
Low Disease Activity and Disease Stability: Setting New Goals for COPD Care
Pulmonology
Low Disease Activity and Disease Stability: Setting New Goals for COPD Care
Infographic

This infographic explores the emerging concepts of disease activity, disease stability, and disease control in COPD.

View more
What Do We Know About Type 2 Inflammation in COPD?
Pulmonology
What Do We Know About Type 2 Inflammation in COPD?
expert video

Join global expert Dr. Michael Wechsler as he discusses type 2 inflammation in COPD.

View more
Prurigo Nodularis Is a Challenging Diagnosis
Dermatology
Prurigo Nodularis Is a Challenging Diagnosis
expert video

Join Dr. Sarina Elmariah as she discusses the challenges in diagnosing prurigo nodularis.

View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2026 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 - 4.0 - 10/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: MalaysiaChange country/region